LB1745 Brilaroxazine topical liposomal-gel formulation displays efficacy in the imiquimod-induced psoriatic BALB/c mouse model

Autor: Bhat, L., Bhat, S.R., Ramakrishnan, A., Amirthalingam, M.
Zdroj: In Journal of Investigative Dermatology September 2023 143(9):B25-B25
Databáze: ScienceDirect